Craneware plc Director Share Purchase (1679R)

TIDMCRW

RNS Number : 1679R

Craneware plc

25 October 2023

Craneware plc

("Craneware" or the "Company" or the "Group")

Director Share Purchase

25 October 2023 - Craneware (AIM: CRW.L), the market leader in automated Value Cycle solutions for the US healthcare market, announces that on 24 October 2023 the Company was notified that on that same day, Will Whitehorn, Chair of the Company, purchased 1,600 ordinary shares of 1p each in the capital of the Company at a price of 1,560 pence per Ordinary Share.

Following the purchase of Ordinary Shares, Mr. Whitehorn holds 4,589 Ordinary Shares in the capital of the Company, representing 0.013% of the Company's issued share capital (excluding Ordinary Shares held in treasury).

Notification and public disclosure of transactions by persons discharging managerial responsibilities and persons closely associated with them:

   1.   Details of the Restricted Person / person closely associated with him or her 
   a) Name                                                             William Whitehorn 
   2.   Reason for the notification 
   a) Position / status                                             Chair 
   b) Initial notification / Amendment                       Initial notification 

3. Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor

   a) Name                                                             Craneware plc 
   b) LEI                                                                213800O2CTJ1YFXNXG05 

4. Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted

a) Description of the financial instrument, type of

instrument Ordinary shares of 1p each in the capital of Craneware plc

   b) Identification code                                           ISIN GB00B2425G68 
   c) Nature of the transaction                                    Purchase of Ordinary Shares 
   d) Price(s) and volume(s)                                      Volume(s)  1,600 , Price(s) GBP15.60 
   e) Aggregated information:                                  N/A (single transaction) 
                                       i. Aggregated volume             - 
                                       ii. Price(s)                              - 
   f) Date of the transaction                                    2023-10-24 
          g) Place of the transaction                                   London Stock Exchange (XLON) 

For further information, please contact:

Craneware plc [phone]

Keith Neilson, CEO

Craig Preston, CFO

Alma (Financial PR) [phone]

Caroline Forde, Joe Pederzolli, Kinvara Verdon [e-mail]

Peel Hunt (NOMAD and Joint Broker) [phone]

Neil Patel, Paul Gillam, Richard Chambers

Investec Bank PLC (Joint Broker) [phone]

Patrick Robb, Henry Reast, Cameron MacRitchie

Berenberg (Joint Broker) [phone]

Mark Whitmore, Richard Andrews, Dan Gee-Summons

About Craneware

The Craneware Group (AIM:CRW.L), the market leader in automated value cycle solutions, including 340B management, collaborates with U.S. healthcare providers to plan, execute, and monitor operational and financial performance so they can continue to deliver quality care to their communities. Customers choose The Craneware Group's Trisus data and applications platform as their key to navigating the journey to financially sustainable value-based care. Trisus combines revenue integrity, cost management, 340B performance, and decision enablement into a single, SaaS-based platform. Trisus Chargemaster secured top ranking in the Chargemaster Management category of the "2023 Best in KLAS Awards: Software & Services" and is part of an extensive value cycle management suite. The Craneware Group - transforming the business of healthcare.

Learn more at www.thecranewaregroup.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact [e-mail] or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.

END

DSHBRBDGBGDDGXS

(END) Dow Jones Newswires

October 25, 2023 02:00 ET (06:00 GMT)